Cancer Research Antibodies
At present, more than 30 antibodies or antibody derivatives have been approved for cancer treatment by FDA, and hundreds of antibodies are in the process of clinical trials. Antibodies have become a new choice for cancer treatment. Anti-cancer antibodies can target a wide range of antigens, including soluble proteins, cancer cell surface antigens and effector cell receptors. The versatility of antibodies enables antibodies to take a variety of mechanisms, including direct blocking of growth factors, regulation of the immune system, and interruption or induction of signal transduction pathways. In addition, antibodies are increasingly used as carriers to improve the specificity of specific chemotherapeutic drugs.
Benefits of Elabscience ® Cancer Antibodies
- High antigen purity:The purity of each recombinant protein used as an immunogen is ≥90%, part of which are ≥ 95%.
- High antibody specificity:Antibodies with high affinity antigen specificity were obtained by antigen affinity purification.
- Full and accurate data of cancer antibodies:WB experimental operation guidelines include all the experimental conditions in the WB experimental process. The products have been strictly verified and the datas are accurate and reliable.
- Comprehensive and accurate experimental data:Multi species and applications quality detection to ensure that each antibody is a high-quality product that has been strictly screened.